12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Sat, 05 Apr 2025 08:06:53 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Server: cloudflare [5] => Nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800} [6] => Vary: Accept-Encoding [7] => X-Powered-By: PHP/7.4.33 [8] => Cache-Control: no-cache, private [9] => Cf-Ray: 92b78c790d5ec5e8-HKG [10] => X-Frame-Options: SAMEORIGIN [11] => X-Xss-Protection: 1; mode=block [12] => X-Content-Type-Options: nosniff [13] => Referrer-Policy: no-referrer-when-downgrade [14] => Cf-Cache-Status: DYNAMIC [15] => Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=Hx6AeuDZPW7mOBizqBb85yk1WnzH3A7%2B9kgBi89jqaAoFu166gyRtmV059%2Fr1JNNjde8qPgw4UYgJdazvgVjOXRfwLQ9XZmw5OgdmWDJz%2FRenxicJQ2Vd89Lmrly4GSKU%2Bg%3D"}],"group":"cf-nel","max_age":604800} [16] => Set-Cookie: UpalLiveSession=eyJpdiI6ImRSZkdJNlA3U3p4YTlPVGdDdzMreXc9PSIsInZhbHVlIjoiVjY5Y3F0K3BjbzBEc2RWZUUzZHc3a3d1U3pBUUlmR1ViZmJUM1pYR3R6SWxTN2kxZU5hQnVhOFY4aG1wSG5NdXFueFRhZ2V6VFZwTDd5S3ZQUHpTQ2c9PSIsIm1hYyI6ImRlZTk0YWQ4NDkyMDVlNzVkMDFiODFjMGM4ZTFlNjZjNzcyNDEyNWYwMTViZTc3OTcwZTRkNzA5MDJmZTg3NmIifQ%3D%3D; HttpOnly; Path=/; Max-Age=94608000; Expires=Tue, 04 Apr 2028 07:40:45 GMT [17] => alt-svc: h3=":443"; ma=86400 [18] => server-timing: cfL4;desc="?proto=TCP&rtt=44883&min_rtt=44697&rtt_var=12713&sent=5&recv=6&lost=0&retrans=0&sent_bytes=3002&recv_bytes=756&delivery_rate=64791&cwnd=80&unsent_bytes=0&cid=3ef7f601f4892935&ts=237&x=0" ) 789

由中国广东省内专家研制、针对新冠肺炎的中成药“肺炎一号”，于周四正式委托药厂量产，药厂预料下周可以陆续出货，供应予省内各医院使用。但该款新药属于医院制剂，根据规定，它只能在已申报的医院内部使用，一般市民暂时无法购买。

据当地媒体报道，该款新药由5味药材制成，配方并未公开，在周二已获得省药品监督管理局优先审批通过，由广东一方制药有限公司生产。按目前公布的资料，该药有效期为半年，仅对轻症患者有治疗功效，并无预防作用，非确诊者毋须服用。，

省药品监管局早前曾进行临床试验，供广州市第八人民医院的50名轻症患者临床服用该款新药，结果50%患者的咳嗽症状消失、52.4%的咽痛症状消失、69.6%的乏力症状消失，整体症状明显好转，具较好的临床价值。

---

// // // //